The FDA issued a warning this week, indicating that the agency is reviewing the potential side effects of Onglyza, a diabetes drug that has been linked to an increased risk of heart failure. The lawyers at Saiontz & Kirk, P.A. are already reviewing potential Onglyza lawsuits… Read More
In recent years, as doctors have continued to switch diabetic patients to a new class of diabetes drugs, which includes the blockbuster medications Januvia, Victoza and Byetta, increasing evidence has emerged suggesting a link between use of the drugs and an increased risk of pancreatic cancer.… Read More
Amid concerns that Byetta, Januvia and other incretin mimetic diabetes drugs may cause pancreatic cancer, pancreatitis, thyroid cancer and other injuries, a growing number of health experts and consumer advocates are calling for the drugs to be recalled from the market, as any potential benefits appear… Read More
A motion has been filed to consolidate all Byetta lawsuits, Victoza lawsuits, Januvia lawsuits and Janumet lawsuits brought throughout the federal court system on behalf of individuals who developed pancreatic cancer after using any of the diabetes drugs, asking a panel of federal judge to centralize… Read More
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Byetta cancer lawsuits, Januvia cancer lawsuits and Victoza cancer lawsuits for users of the popular diabetes drugs who have been diagnosed with pancreatic cancer. Financial compensation may be available as a result of the… Read More
